David Bleakman
Director Técnico/Científico/I+D en Redpin Therapeutics, Inc. .
Cargos activos de David Bleakman
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Director Técnico/Científico/I+D | 15/10/2018 | - |
Historial de carrera de David Bleakman
Estadísticas
Internacional
| Estados Unidos | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Commercial Services |
- Bolsa de valores
- Insiders
- David Bleakman
- Experiencia
